Your browser doesn't support javascript.
loading
Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
de Galan, B E; Zoungas, S; Chalmers, J; Anderson, C; Dufouil, C; Pillai, A; Cooper, M; Grobbee, D E; Hackett, M; Hamet, P; Heller, S R; Lisheng, L; MacMahon, S; Mancia, G; Neal, B; Pan, C Y; Patel, A; Poulter, N; Travert, F; Woodward, M.
Afiliación
  • de Galan BE; The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia.
  • Zoungas S; Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
  • Chalmers J; The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia. szoungas@george.org.au.
  • Anderson C; Monash University, Melbourne, VIC, Australia. szoungas@george.org.au.
  • Dufouil C; The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia.
  • Pillai A; The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia.
  • Cooper M; INSERM U708, Paris, France.
  • Grobbee DE; UPMC University of Paris, Paris, France.
  • Hackett M; The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia.
  • Hamet P; Baker IDI Heart Research Institute, Melbourne, VIC, Australia.
  • Heller SR; Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Lisheng L; The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia.
  • MacMahon S; Centre Hospitalier de l'Université de Montreal and Université de Montreal, Montreal, QC, Canada.
  • Mancia G; University of Sheffield and Sheffield Teaching Hospitals National Health Service Foundation Trust, Sheffield, UK.
  • Neal B; Chinese Hypertension League Institute, Beijing, China.
  • Pan CY; The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia.
  • Patel A; University of Milan-Bicocca and San Gerardo Hospital, Milan, Italy.
  • Poulter N; The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia.
  • Travert F; Chinese People's Liberation Army General Hospital, Beijing, China.
  • Woodward M; The George Institute for International Health, The University of Sydney, PO Box M201, Missenden Road, Camperdown, Sydney, NSW, 2050, Australia.
Diabetologia ; 52(11): 2328-2336, 2009 Nov.
Article en En | MEDLINE | ID: mdl-19688336
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cognición / Perindopril / Diabetes Mellitus Tipo 2 / Angiopatías Diabéticas / Gliclazida / Hipoglucemia / Indapamida Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Diabetologia Año: 2009 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Cognición / Perindopril / Diabetes Mellitus Tipo 2 / Angiopatías Diabéticas / Gliclazida / Hipoglucemia / Indapamida Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Diabetologia Año: 2009 Tipo del documento: Article País de afiliación: Australia